|
Volumn 109, Issue 1, 2013, Pages 178-179
|
Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): Solid evidence or "no-go"?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER CONTROL;
CANCER GRADING;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CHEST INFECTION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
ESOPHAGUS;
FOLLOW UP;
GREAT BLOOD VESSEL;
HEALTH CARE PERSONNEL;
HEART;
HUMAN;
LETTER;
LUNG NON SMALL CELL CANCER;
MAXIMUM TOLERATED DOSE;
MEDIASTINUM;
MULTICENTER STUDY (TOPIC);
NECROSIS;
ORGANS AT RISK;
OUTCOME ASSESSMENT;
PATIENT SAFETY;
PATIENT SELECTION;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHRENIC NERVE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RADIATION DOSE;
RADIATION DOSE FRACTIONATION;
RETROSPECTIVE STUDY;
STEREOTACTIC BODY RADIATION THERAPY;
THERAPY EFFECT;
TRACHEOBRONCHIAL TREE;
TREATMENT PLANNING;
TUMOR VOLUME;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
RADIOSURGERY;
|
EID: 84888026687
PISSN: 01678140
EISSN: 18790887
Source Type: Journal
DOI: 10.1016/j.radonc.2013.07.022 Document Type: Letter |
Times cited : (15)
|
References (8)
|